Aurobindo unit gets USFDA nod to market generic asthma medication

Business and Industry — · 0 Comment
Post Views: 40

The company’s product is therapeutically equivalent to AstraZeneca Pharmaceuticals LP’s Pulmicort Repsules Inhalation Suspension, it added

Leave a Reply

Your email address will not be published. Required fields are marked *

©2024 SAIWEBS WordPress Theme by WPEnjoy